Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective

Abstract

The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.